Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol as a protective agent in postoperative attentional changes
RBR-6xhp399Completed
- Sponsor
- Hospital Universitário Gaffrée e Guinle
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of propofol and sevoflurane (3 arms), sponsored by Hospital Universitário Gaffrée e Guinle. Primary endpoint: Postoperative cognitive dysfunction and attentional change. Started Sep 2023; status: completed.
02
Drugs
propofolsevoflurane
Beyond the preview
Go deeper on RBR-6xhp399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6xhp399.